In agreement, exogenous administration of AT2 receptor by nanoparticles was found to significantly attenuate lung cancer growth in an orthotopic model of syngeneic tumor grafts (Kawabata et al., 2012). This evidence concerns the gene AGTR2 and lung carcinoma.